These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 28712240
1. Hepatorenal Syndrome In Patients With Cirrhosis Of Liver According To 2007 International Ascites Club Criteria. Seetlani NK, Memon AR, Iftikhar F, Ali A, Fazel PA. J Ayub Med Coll Abbottabad; 2016; 28(3):578-581. PubMed ID: 28712240 [Abstract] [Full Text] [Related]
2. Frequency of hepatorenal syndrome among cirrhotics. Kumar R, Ahmed R, Rathi SK, Sethar GH. J Coll Physicians Surg Pak; 2005 Oct; 15(10):590-3. PubMed ID: 19810292 [Abstract] [Full Text] [Related]
3. Precipitating Factors and Outcome of Hepatorenal Syndrome in Liver Cirrhosis. Chinnasamy V, Dhande SK, Kumar KM, M J. J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116041 [Abstract] [Full Text] [Related]
4. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U. Hepatogastroenterology; 2003 Jan; 50(54):1753-5. PubMed ID: 14696397 [Abstract] [Full Text] [Related]
5. Hepatorenal syndrome: diagnostic accuracy, clinical features, and outcome in a tertiary care center. Watt K, Uhanova J, Minuk GY. Am J Gastroenterol; 2002 Aug; 97(8):2046-50. PubMed ID: 12190175 [Abstract] [Full Text] [Related]
6. Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation. Wong F, Leung W, Al Beshir M, Marquez M, Renner EL. Liver Transpl; 2015 Mar; 21(3):300-7. PubMed ID: 25422261 [Abstract] [Full Text] [Related]
7. Prevalence of Acute Kidney Injury in Patients with Liver Cirrhosis. Thapa P, Kc S, Hamal AB, Sharma D, Khadka S, Karki N, Jaishi B, Tiwari PS, Vaidya A, Karki A. JNMA J Nepal Med Assoc; 2020 Aug 31; 58(228):554-559. PubMed ID: 32968287 [Abstract] [Full Text] [Related]
8. Frequency, pattern and short-term outcome of chronic renal dysfunction in patients with cirrhosis: a prospective study using HRS and ADQI-IAC criteria. De Silva ST, Perera RP, Niriella MA, Pathmeswaran A, de Silva HJ. Eur J Gastroenterol Hepatol; 2014 Nov 31; 26(11):1296-9. PubMed ID: 25171022 [Abstract] [Full Text] [Related]
9. Renal duplex Doppler ultrasound in patients with HCV related liver cirrhosis. Fouad YM, Mokarrab H, Elgebaly AF, El-Amin H, Abdel-Raheem EM, Sharawy MA, Shatat ME. Trop Gastroenterol; 2009 Nov 31; 30(4):213-8. PubMed ID: 20426281 [Abstract] [Full Text] [Related]
10. [Hepatorenal syndrome]. Pŭrvanov P. Khirurgiia (Sofiia); 2002 Nov 31; 58(2):34-9. PubMed ID: 12515019 [Abstract] [Full Text] [Related]
11. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Ginès A, Escorsell A, Ginès P, Saló J, Jiménez W, Inglada L, Navasa M, Clària J, Rimola A, Arroyo V. Gastroenterology; 1993 Jul 31; 105(1):229-36. PubMed ID: 8514039 [Abstract] [Full Text] [Related]
12. RRI as Diagnostic and Follow up Indicator in Cirrhosis of the Liver with Hepatorenal Syndrome and Refractory Ascites. C AK, L P, Krishnamurthy A. J Assoc Physicians India; 2019 Apr 31; 67(4):22-25. PubMed ID: 31299833 [Abstract] [Full Text] [Related]
13. Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis. Dong T, Aronsohn A, Gautham Reddy K, Te HS. Dig Dis Sci; 2016 Dec 31; 61(12):3621-3626. PubMed ID: 27655104 [Abstract] [Full Text] [Related]
14. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1. Boyer TD, Sanyal AJ, Wong F, Frederick RT, Lake JR, O'Leary JG, Ganger D, Jamil K, Pappas SC, REVERSE Study Investigators. Gastroenterology; 2016 Jun 31; 150(7):1579-1589.e2. PubMed ID: 26896734 [Abstract] [Full Text] [Related]
15. Management and outcomes of hepatorenal syndrome at an urban academic medical center: a retrospective study. Bashir MH, Iqbal S, Miller R, Singh J, Mubarak G, Likhtshteyn M, Bigajer E, Gallagher B, Hurairah A, Stefanov D, McFarlane SI, Ferstenberg R. Eur J Gastroenterol Hepatol; 2019 Dec 31; 31(12):1545-1549. PubMed ID: 31169567 [Abstract] [Full Text] [Related]
16. Sequential treatment of hepatorenal syndrome and posthepatic cirrhosis by intrahepatic portosystemic shunt (TIPSS) and liver transplantation. Lerut J, Goffette P, Laterre PF, Donataccio M, Reynaert MS, Otte JB. Hepatogastroenterology; 1995 Dec 31; 42(6):985-7. PubMed ID: 8847056 [Abstract] [Full Text] [Related]
17. Does Anemia Have a Potential Effect on Type 2 Hepatorenal Syndrome? Bizid S, Yacoub H, Mohamed G, Ben Slimane B, Boughoula K, Ben Abdallah H, Bouali R, Abedelli N. Can J Gastroenterol Hepatol; 2020 Dec 31; 2020():1134744. PubMed ID: 33381474 [Abstract] [Full Text] [Related]
18. Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites. Sersté T, Lebrec D, Valla D, Moreau R. Acta Gastroenterol Belg; 2008 Dec 31; 71(1):9-14. PubMed ID: 18396743 [Abstract] [Full Text] [Related]
19. Hepatorenal syndrome and novel advances in its management. Fabrizi F, Aghemo A, Messa P. Kidney Blood Press Res; 2013 Dec 31; 37(6):588-601. PubMed ID: 24356549 [Abstract] [Full Text] [Related]